MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Diet & Clinical Outcomes in Multiple Sclerosis
  • Study Provides New Insights Into Disease Progression
  • ECTRIMS 2024: An Overview
  • Bile Acids: A Novel Multiple Sclerosis Therapy?
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

Epstein-Barr virus and multiple sclerosis

Is Epstein-Barr Virus the Cause of Multiple Sclerosis?

MStranslate
January 17, 2022
Epstein-Barr virus, Research
A new study from Harvard University has provided more evidence supporting a link between Epstein-Barr virus (EBV) infection and multiple sclerosis. In the video below, MStranslate co-founder and chief...
COVID-19 vaccine

Multiple Sclerosis and the COVID-19 Vaccine

MStranslate
January 12, 2022
COVID-19, Dr Sally Shaw, Infection
5 Comments
UPDATED I don’t think it would be much of a stretch to say that the last two years have been dominated by the coronavirus pandemic.  In a continually changing environment, we have recognised the need to...
AHSCT

Real World Application of AHSCT in MS

MStranslate
December 22, 2021
Research, Stem Cells, Treatments
Written by Brett Drummond (MStranslate co-founder), in collaboration with Joey Lambert (MStranslate intern) Autologous haematopoietic stem cell transplantation (AHSCT) is an exciting, recently developed...
Surplus Suffering

Surplus Suffering in MS: An Exclusive Interview

MStranslate
December 16, 2021
Dr Sally Shaw, Research, Videos
While MStranslate has been built upon a desire to report on the latest developments in multiple sclerosis research as they occur, we are also committed to sharing and illuminating the lived experience of MS....
remyelination

Latest Remyelination Research Developments in MS

MStranslate
November 24, 2021
Dr Travis Stiles, ECTRIMS, Remyelination, Research, Videos
In his first feature as an official member of the MStranslate team, Novoron Bioscience CEO, Dr Travis Stiles, recently sat down with our co-founder, Brett Drummond, to discuss the latest developments in...
ECTRIMS Congress 2021

ECTRIMS Congress 2021: Research Insights

MStranslate
October 18, 2021
Conferences, Dr Travis Stiles, ECTRIMS, Research, Videos
Due to the ongoing challenges and restrictions of the COVID-19 pandemic, ECTRIMS Congress 2021 was once again held as a virtual conference this year.  Taking place between October 13 and 15, this meeting...
Dr Travis Stiles

Dr Travis Stiles Officially Joins MStranslate

MStranslate
October 13, 2021
Collaboration, Community, Dr Travis Stiles
1 Comment
Many in our community will recognise Dr Travis Stiles (CEO, Novoron Bioscience), as he has been a regular guest contributor to MStranslate since 2016.  Now, we can excitedly share that Travis is joining the...
Multiple Sclerosis Cure

Community Q&A: Why Don’t We Have An MS Cure?

MStranslate
October 11, 2021
Community, Opinion, Q&A
In this video, our co-founder and chief science communicator, Brett Drummond, answers one of the recent questions submitted by a member of the MStranslate community. In this instance, he shares his opinions on...
COVID-19 vaccines

Community Q&A: COVID-19 Vaccines & MS

MStranslate
September 29, 2021
Community, COVID-19, Q&A, Research
In this video, our co-founder and chief science communicator, Brett Drummond, answers one of the recent questions submitted by a member of the MStranslate community. In this instance, it looks at the latest...
blood-brain barrier

Community Q&A: The Blood-Brain Barrier

MStranslate
September 23, 2021
Community, Q&A, Research
1 Comment
What is the blood-brain barrier? Why is the blood-brain barrier important in multiple sclerosis (MS)?  Is research being undertaken to repair the blood-brain barrier in people living with multiple sclerosis,...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Posts

  • Multiple Sclerosis in 2025 – Key Developments to Date
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Diet & Clinical Outcomes in Multiple Sclerosis
  • Study Provides New Insights Into Disease Progression
  • ECTRIMS 2024: An Overview

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkValues & Standards